Cdz173 Free Base Uses, Dosage, Side Effects and more
Cdz173 Free Base is under investigation in clinical trial NCT02435173 (Study of Efficacy of CDZ173 in Patients With APDS/PASLI).
| Trade Name | Cdz173 Free Base |
| Generic | Leniolisib |
| Leniolisib Other Names | Cdz-173 free base, Cdz173 free base, Leniolisib |
| Type | |
| Formula | C21H25F3N6O2 |
| Weight | Average: 450.466 Monoisotopic: 450.199108558 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
